Guardant Health
GH
#3559
Rank
A$4.62 B
Marketcap
$37.63
Share price
-1.18%
Change (1 day)
-11.90%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total debt

Total debt on the balance sheet as of June 2024 : A$2.01 B

According to Guardant Health 's latest financial reports the company's total debt is A$2.01 B. A companyโ€™s total debt is the sum of all current and non-current debts.

Guardant Health - Total debt on balance sheet (from 2017 to 2024)

Total debt by year

Year Total debt Change
2023-12-31A$1.98 B-1.25%
2022-12-31A$2.01 B6.5%
2021-12-31A$1.88 B70.37%
2020-12-31A$1.10 B1829.7%
2019-12-31A$57.46 M
2018-12-31N/A-100%
2017-12-31A$0.84 M-96.43%
2016-12-31A$23.63 M

Total debt for similar companies or competitors

Company Total debt differencediff. Country
A$0.65 B-67.37%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.33 B-33.57%๐Ÿ‡บ๐Ÿ‡ธ USA